ArticlePoultry science2026
Rapid detection of Chlamydia Psittaci by isothermal recombinase polymerase amplification assays.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chlamydia psittaci (Cps) is a zoonotic pathogen widely distributed in nature that strictly parasitizes eukaryotic cells. Cps is typically carried by parrots and other birds, possesses high virulence and toxicity, and can cause psittacosis in humans and animals. Therefore, monitoring and preventing the spread of psittacosis holds significant economic and public health importance. In this study, the specific primers and probes targeting the CPSIT_0429 gene of Cps were designed and synthesized, and recombinase polymerase amplification (RPA) assays were developed. Utilizing a real-time fluorescence detection platform (qRPA) and a lateral flow strip combined with RPA (LFS RPA), the rapid and effective detection of Cps was achieved. The limit of detection for the qRPA assay and the LFS RPA assay with Cps DNA standards was 120 copies/uL and 13 copies/uL, respectively. The developed qRPA and LFS RPA could specifically detect Cps without cross-reactings with other common respiratory pathogens tested in this study. The qRPA assay and the LFS RPA assay were further evaluated on 334 clinical oropharyngeal-cloacal swabs, feces, and lung samples, and the detection rates of CPs were 4.80% (16/334) and 5.70% (19/334) for the qRPA and the LFS RPA, respectively. Compared with qPCR detection results, the concordance rates were 98.80% and 99.70%, respectively. Furthermore, A, B and E genotype of Cps were identified in the above positive samples. These results indicated that the qRPA assay and the LFS RPA assay developed in this study could serve as effective diagnostic tools of Cps, especially in the field detection and in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.